Dômes Pharma Group Acquires Sentrx Animal Care

"We are delighted to have finalized the acquisition of Sentrx Animal Care in such a short space of time. The geographic, industrial and therapeutic synergies between our two companies are so obvious that we were made for each other...”

LEARN MORE »

Introducing the New Ocular Immersion Tool From Sentrx & Dômes Pharma

Use our interactive eye model to delve into specific ocular problems in more detail.

Sign up to take a look at this new tool now.

LEARN MORE »

Extraordinary Solutions.
Exceptional Pet Comfort.

Learn about BioHAnce™ our patented crosslinked Hyaluronic Acid technology. BioHAnce helps to increase compliance and improve outcomes unlike traditional eye drops or support for wound care.

LEARN MORE »
Ocunovis ProCare BioHAnce Gel Eye Drops

Advanced hydration with fewer applications brings long-term comfort for pets.

LEARN MORE

SentrX-Home-Page-Oculenis-Logo

Accelerated healing and easy application means greater comfort.

LEARN MORE

SentrX-Home-Page-Episanis-Logo

Faster dermal healing and easy application help reduce risk, pain and cone time.

LEARN MORE

Our revolutionary BioHAnce™ Technology platform sets Sentrx products apart from anything available.

BioHAnce™ is at the forefront of innovation in ophthalmology and epidermal healing that features a patented cross-linked Hyaluronic Acid (HA). HA is a naturally occurring molecule throughout the animal's body that plays a role in lubrication, hydration and healing. The highest concentrations are found in the eyes and skin. BioHAnce is a patented platform that uses advanced bioengineering technology to create a form of HA with greater activity in less volume that also lasts longer. BioHAnce is uniquely designed to accelerate the natural healing process and extend the duration in ocular and epidermal tissues, which traditional HA connot achieve.

LEARN MORE

Novel solutions in comfort bring benefits to everyone dedicated to pets.

Novel solutions in comfort bring benefits to everyone dedicated to pets.